HsinLi Chemical Industrial Corp. (TPEX:4303)

Ligand Pharmaceuticals Income Statement

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	767.71	373.93	161.72	325.36	365	332.96
Revenue Growth (YoY)	326.23%	131.21%	-50.29%	-10.86%	9.62%	-21.27%
Cost of Revenue	654.08	330.17	152.61	263.66	303.26	285.08
Gross Profit	113.64	43.76	9.12	61.71	61.74	47.89
Selling, General & Admin	180.97	109.65	36.07	39.51	35.52	29.88
Research & Development	25	8.61	3.17	5.35	7.63	10.08
Operating Expenses	205.34	117.68	39.24	44.46	43.15	38.39
Operating Income	-91.7	-73.92	-30.12	17.25	18.59	9.5
Interest Expense	-13.48	-7.23	-5.67	-5.75	-2.13	-1.82
Interest & Investment Income	17.77	16.2	10.51	17.82	9.06	11.06
Earnings From Equity Investments	-	-	-	-0.74	0.08	-0.12
Currency Exchange Gain (Loss)	5.76	5.76	-0.01	0.95	-0.4	-0.47
Other Non Operating Income (Expenses)	1,298	882.62	155.02	-67.53	5.98	2.96
EBT Excluding Unusual Items	1,217	823.43	129.73	-38	31.18	21.1
Gain (Loss) on Sale of Investments	-	-	-	-	109.38	-47.61
Gain (Loss) on Sale of Assets	0.42	0.42	0.1	-	-0.32	-0.23
Other Unusual Items	-1.3	-1.3	-5.14	0.04	-	0.01
Pretax Income	1,216	822.55	124.69	-37.95	140.24	-26.72
Income Tax Expense	34.63	8.38	1.24	3.24	3.47	1.71
Earnings From Continuing Operations	1,181	814.18	123.46	-41.2	136.77	-28.43
Net Income to Company	1,181	814.18	123.46	-41.2	136.77	-28.43
Minority Interest in Earnings	6.51	2.98	-	-	-	-
Net Income	1,188	817.16	123.46	-41.2	136.77	-28.43
Net Income to Common	1,188	817.16	123.46	-41.2	136.77	-28.43
Net Income Growth	221.21%	561.88%	-	-	-	-
Shares Outstanding (Basic)	79	77	68	68	70	70
Shares Outstanding (Diluted)	79	79	79	68	70	70
Shares Change (YoY)	0.42%	0.30%	16.93%	-3.38%	-0.19%	-0.09%
EPS (Basic)	15.07	10.62	1.83	-0.61	1.96	-0.41
EPS (Diluted)	14.98	10.33	1.60	-0.61	1.96	-0.41
EPS Growth	218.65%	545.82%	-	-	-	-
Free Cash Flow	-6.94	32.06	7.89	-37.65	58.28	12.21
Free Cash Flow Per Share	-0.09	0.41	0.10	-0.56	0.83	0.17
Dividend Per Share	1.000	1.000	1.164	-	1.100	0.300
Dividend Growth	-14.12%	-14.12%	-	-	266.67%	-75.00%
Gross Margin	14.80%	11.70%	5.64%	18.97%	16.91%	14.38%
Operating Margin	-11.95%	-19.77%	-18.63%	5.30%	5.09%	2.85%
Profit Margin	154.71%	218.53%	76.34%	-12.66%	37.47%	-8.54%
Free Cash Flow Margin	-0.90%	8.57%	4.88%	-11.57%	15.97%	3.67%
EBITDA	-49.22	-45.5	-6.25	36.67	40.67	32.16
EBITDA Margin	-6.41%	-12.17%	-3.86%	11.27%	11.14%	9.66%
D&A For EBITDA	42.48	28.42	23.88	19.42	22.08	22.66
EBIT	-91.7	-73.92	-30.12	17.25	18.59	9.5
EBIT Margin	-11.95%	-19.77%	-18.63%	5.30%	5.09%	2.85%
Effective Tax Rate	2.85%	1.02%	0.99%	-	2.48%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.